首页 > 最新文献

Pathologie-biologie最新文献

英文 中文
IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay IgD多发性骨髓瘤:血清游离轻链试验的临床、生物学特征和预后价值
Pub Date : 2015-09-01 DOI: 10.1016/j.patbio.2015.06.002
R. Djidjik , Y. Lounici , K. Chergeulaïne , Y. Berkouk , S. Mouhoub , S. Chaib , M. Belhani , M. Ghaffor

IgD multiple myeloma (MM) is a rare subtype of myeloma, it affects less than 2% of patients with MM. To evaluate the clinical and prognostic attributes of serum free light chains (sFLCs) analysis, we examined 17 cases of IgD MM. From 1998 to 2012, we obtained 1250 monoclonal gammapathies including 590 multiple myeloma and 17 patients had IgD MM. With preponderance of men patients with a mean age at diagnosis of: 59 ± 12 years. Patients with IgD MM have a short survival (Median survival = 9 months). The presenting features included: bone pain (75%), lymphadenopathy (16%), hepatomegaly (25%), splenomegaly (8%), associated AL amyloidosis (6%), renal impairment function (82%), infections (47%), hypercalcemia (37%) and anemia (93%). Serum electrophoresis showed a subtle M-spike (Mean = 13.22 ± 10 g/L) in all patients associated to a hypogammaglobulinemia. There was an over-representation of Lambda light chain (65%); high serum β2-microglobulin in 91% and Bence Jones proteinuria was identified in 71%. The median rate of sFLCs κ was 19.05 mg/L and 296.75 mg/L for sFLCs λ. sFLCR was abnormal in 93% of patients and it showed concordance between baseline sFLCR and the survival (P = 0.034). The contribution of FLC assay is crucial for the prognosis of patients with IgD MM.

IgD多发性骨髓瘤(MM)是一种罕见的骨髓瘤亚型,影响不到2%的MM患者。为了评估血清游离轻链(sFLCs)分析的临床和预后特征,我们检查了17例IgD MM。从1998年到2012年,我们获得了1250例单克隆γ病变,包括590例多发性骨髓瘤和17例IgD MM。男性患者占优势,平均诊断年龄为:59±12岁。IgD MM患者的生存期较短(中位生存期= 9个月)。主要表现为:骨痛(75%)、淋巴结病(16%)、肝肿大(25%)、脾肿大(8%)、相关AL淀粉样变(6%)、肾功能损害(82%)、感染(47%)、高钙血症(37%)和贫血(93%)。所有低丙种球蛋白血症患者的血清电泳显示一个微妙的m峰(平均= 13.22±10 g/L)。Lambda轻链的比例过高(65%);91%的患者血清β2-微球蛋白增高,71%的患者有本·琼斯蛋白尿。sFLCs λ κ的中位率分别为19.05 mg/L和296.75 mg/L。93%的患者sFLCR异常,基线sFLCR与生存率一致(P = 0.034)。FLC检测对IgD MM患者的预后至关重要。
{"title":"IgD multiple myeloma: Clinical, biological features and prognostic value of the serum free light chain assay","authors":"R. Djidjik ,&nbsp;Y. Lounici ,&nbsp;K. Chergeulaïne ,&nbsp;Y. Berkouk ,&nbsp;S. Mouhoub ,&nbsp;S. Chaib ,&nbsp;M. Belhani ,&nbsp;M. Ghaffor","doi":"10.1016/j.patbio.2015.06.002","DOIUrl":"10.1016/j.patbio.2015.06.002","url":null,"abstract":"<div><p>IgD multiple myeloma (MM) is a rare subtype of myeloma, it affects less than 2% of patients with MM. To evaluate the clinical and prognostic attributes of serum free light chains (sFLCs) analysis, we examined 17 cases of IgD MM. From 1998 to 2012, we obtained 1250 monoclonal gammapathies including 590 multiple myeloma and 17 patients had IgD MM. With preponderance of men patients with a mean age at diagnosis of: 59<!--> <!-->±<!--> <!-->12<!--> <!-->years. Patients with IgD MM have a short survival (Median survival<!--> <!-->=<!--> <!-->9<!--> <!-->months). The presenting features included: bone pain (75%), lymphadenopathy (16%), hepatomegaly (25%), splenomegaly (8%), associated AL amyloidosis (6%), renal impairment function (82%), infections (47%), hypercalcemia (37%) and anemia (93%). Serum electrophoresis showed a subtle M-spike (Mean<!--> <!-->=<!--> <!-->13.22<!--> <!-->±<!--> <!-->10<!--> <!-->g/L) in all patients associated to a hypogammaglobulinemia. There was an over-representation of Lambda light chain (65%); high serum β2-microglobulin in 91% and Bence Jones proteinuria was identified in 71%. The median rate of sFLCs κ was 19.05<!--> <!-->mg/L and 296.75<!--> <!-->mg/L for sFLCs λ. sFLCR was abnormal in 93% of patients and it showed concordance between baseline sFLCR and the survival (<em>P</em> <!-->=<!--> <!-->0.034). The contribution of FLC assay is crucial for the prognosis of patients with IgD MM.</p></div>","PeriodicalId":19743,"journal":{"name":"Pathologie-biologie","volume":"63 4","pages":"Pages 210-214"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.patbio.2015.06.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34109054","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 13
Lupus érythémateux systémique se présentant comme un syndrome de Stevens-Johnson 系统性红斑狼疮表现为史蒂文-约翰逊综合征
Pub Date : 2015-09-01 DOI: 10.1016/j.patbio.2015.05.001
S. Bellakhal, B. Ben Kaab, Z. Teyeb, A. Souissi, F. Derbel, M.-H. Douggui

Stevens-Johnson syndrome and toxic epidermal necrolysis are life-threatening dermatological conditions. Their most common cause is medication. However, in a small proportion of patients these dermatological conditions could be the first presentation of systemic lupus erythematosus. We now describe a 34-year-old patient who presented with manifestations of Stevens-Johnson as a first feature of systemic lupus erythematosus. Systemic lupus erythematosus reveled by Stevens-Johnson syndrome has been infrequently reviewed in the previous literature. This diagnosis should be considered when cutaneous adverse drug reactions occur without clear drug causality.

史蒂文斯-约翰逊综合征和中毒性表皮坏死松解是危及生命的皮肤病。最常见的原因是药物治疗。然而,在一小部分患者中,这些皮肤病可能是系统性红斑狼疮的首次表现。我们现在描述一个34岁的病人谁提出史蒂文斯-约翰逊的表现作为系统性红斑狼疮的第一个特征。史蒂文斯-约翰逊综合征引起的系统性红斑狼疮在以前的文献中很少被回顾。当皮肤药物不良反应没有明确的药物因果关系时,应考虑此诊断。
{"title":"Lupus érythémateux systémique se présentant comme un syndrome de Stevens-Johnson","authors":"S. Bellakhal,&nbsp;B. Ben Kaab,&nbsp;Z. Teyeb,&nbsp;A. Souissi,&nbsp;F. Derbel,&nbsp;M.-H. Douggui","doi":"10.1016/j.patbio.2015.05.001","DOIUrl":"10.1016/j.patbio.2015.05.001","url":null,"abstract":"<div><p>Stevens-Johnson syndrome and toxic epidermal necrolysis are life-threatening dermatological conditions. Their most common cause is medication. However, in a small proportion of patients these dermatological conditions could be the first presentation of systemic lupus erythematosus. We now describe a 34-year-old patient who presented with manifestations of Stevens-Johnson as a first feature of systemic lupus erythematosus. Systemic lupus erythematosus reveled by Stevens-Johnson syndrome has been infrequently reviewed in the previous literature. This diagnosis should be considered when cutaneous adverse drug reactions occur without clear drug causality.</p></div>","PeriodicalId":19743,"journal":{"name":"Pathologie-biologie","volume":"63 4","pages":"Pages 222-223"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.patbio.2015.05.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33275103","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 2
Stress in biology and medicine, role in aging 生物和医学中的压力,在衰老中的作用
Pub Date : 2015-09-01 DOI: 10.1016/j.patbio.2015.07.008
L. Robert, J. Labat-Robert

In this review, we present a short description of the history of stress in the medical literature followed by a recapitulation of its mechanisms, from the cellular to the organismal level and its role in aging. The medical importance of stress was first taken up as a subject of experimental medicine by physiologists, starting from Claude Bernard's concept of the stability of the “milieu intérieur”, altered by stress, followed by others, culminating recently by the elucidation of its mechanisms at the cellular and molecular level. These studies showed that oxidative stress is one of the most important and most frequent form of biological aggression. Its accumulation over time is important for the burnout syndrome and for neuronal aging. There is however a positive side to it also, redox signaling plays an important role in the functional coordination of cellular activities. These mechanisms, still to be more completely evaluated, have to be taken in account for planning efficient protective therapeutic interventions.

在这篇综述中,我们简要介绍了医学文献中压力的历史,然后概述了它的机制,从细胞到组织水平及其在衰老中的作用。压力在医学上的重要性首先是由生理学家作为实验医学的一个主题来研究的,从克劳德·伯纳德提出的被压力改变的"内部环境"的稳定性概念开始,然后是其他概念,最近在细胞和分子水平上对其机制的阐明达到了高潮。这些研究表明,氧化应激是最重要和最常见的生物攻击形式之一。随着时间的推移,它的积累对倦怠综合征和神经元老化很重要。然而,它也有积极的一面,氧化还原信号在细胞活动的功能协调中起着重要作用。在规划有效的保护性治疗干预措施时,必须考虑到这些仍有待更全面评估的机制。
{"title":"Stress in biology and medicine, role in aging","authors":"L. Robert,&nbsp;J. Labat-Robert","doi":"10.1016/j.patbio.2015.07.008","DOIUrl":"10.1016/j.patbio.2015.07.008","url":null,"abstract":"<div><p>In this review, we present a short description of the history of stress in the medical literature followed by a recapitulation of its mechanisms, from the cellular to the organismal level and its role in aging. The medical importance of stress was first taken up as a subject of experimental medicine by physiologists, starting from Claude Bernard's concept of the stability of the “milieu intérieur”, altered by stress, followed by others, culminating recently by the elucidation of its mechanisms at the cellular and molecular level. These studies showed that oxidative stress is one of the most important and most frequent form of biological aggression. Its accumulation over time is important for the burnout syndrome and for neuronal aging. There is however a positive side to it also, redox signaling plays an important role in the functional coordination of cellular activities. These mechanisms, still to be more completely evaluated, have to be taken in account for planning efficient protective therapeutic interventions.</p></div>","PeriodicalId":19743,"journal":{"name":"Pathologie-biologie","volume":"63 4","pages":"Pages 230-234"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.patbio.2015.07.008","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33963279","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 16
CXCL12 and CXCR4 as predictive biomarkers of glioma recurrence pattern after total resection CXCL12和CXCR4作为胶质瘤全切除后复发模式的预测性生物标志物
Pub Date : 2015-09-01 DOI: 10.1016/j.patbio.2015.07.002
W. Tang , X. Wang , Y. Chen , J. Zhang , Y. Chen , Z. Lin

Purpose of the study

Previous studies have shown that the pattern of recurrence for glioma is related to the direction of glioma cell invasion. Recent studies demonstrated that the CXCL12/CXCR4 signaling pathway mediates cellular invasion in glioma. Therefore, in this study, we investigated the possible relationship between CXCL12/CXCR4 expression and recurrence pattern in glioma.

Patients and methods

Immunohistochemical techniques were used to assess CXCL12/CXCR4 expression in 42 glioma tissues following total resection. According to magnetic resonance imaging (MRI) of gliomas, the recurrence pattern was classified as close or distant pattern. The relationship between recurrence pattern and CXCL12/CXCR4 expression were initially examined by Chi-squared analysis. The prognostic significance of CXCL12 and CXCR4 was determined by log-rank tests and COX proportional hazards model.

Results

CXCL12 was expressed mainly in vascular endothelial cells and CXCR4 was expressed mainly in tumor cells. The recurrence pattern was significantly related to the expression level of CXCL12 in vascular endothelial cells (P = 0.002) and CXCR4 in tumor cells (P = 0.004). However, CXCL12 and CXCR4 were not independent prognostic factors for progression-free survival or overall survival in glioma patients.

Conclusion

The glioma recurrence pattern is related to CXCL12 expression levels in vascular endothelial cells and CXCR4 expression levels in tumor cells; thus, implicating the CXCL12/CXCR4 signaling pathway as a potential target for glioma therapy.

研究目的既往研究表明胶质瘤的复发方式与胶质瘤细胞侵袭方向有关。最近的研究表明,CXCL12/CXCR4信号通路介导胶质瘤的细胞侵袭。因此,在本研究中,我们探讨了CXCL12/CXCR4表达与胶质瘤复发模式之间的可能关系。采用免疫组化技术评估42例胶质瘤全切除术后组织中CXCL12/CXCR4的表达。根据脑胶质瘤的磁共振成像(MRI),复发类型分为近端复发和远端复发。复发方式与CXCL12/CXCR4表达的关系初步采用卡方分析。通过log-rank检验和COX比例风险模型确定CXCL12和CXCR4的预后意义。结果scxcl12主要在血管内皮细胞中表达,CXCR4主要在肿瘤细胞中表达。复发方式与血管内皮细胞中CXCL12表达水平(P = 0.002)和肿瘤细胞中CXCR4表达水平(P = 0.004)相关。然而,CXCL12和CXCR4并不是胶质瘤患者无进展生存期或总生存期的独立预后因素。结论胶质瘤复发模式与血管内皮细胞中CXCL12表达水平和肿瘤细胞中CXCR4表达水平有关;因此,暗示CXCL12/CXCR4信号通路是神经胶质瘤治疗的潜在靶点。
{"title":"CXCL12 and CXCR4 as predictive biomarkers of glioma recurrence pattern after total resection","authors":"W. Tang ,&nbsp;X. Wang ,&nbsp;Y. Chen ,&nbsp;J. Zhang ,&nbsp;Y. Chen ,&nbsp;Z. Lin","doi":"10.1016/j.patbio.2015.07.002","DOIUrl":"10.1016/j.patbio.2015.07.002","url":null,"abstract":"<div><h3>Purpose of the study</h3><p>Previous studies have shown that the pattern of recurrence for glioma is related to the direction of glioma cell invasion. Recent studies demonstrated that the CXCL12/CXCR4 signaling pathway mediates cellular invasion in glioma. Therefore, in this study, we investigated the possible relationship between CXCL12/CXCR4 expression and recurrence pattern in glioma.</p></div><div><h3>Patients and methods</h3><p>Immunohistochemical techniques were used to assess CXCL12/CXCR4 expression in 42 glioma tissues following total resection. According to magnetic resonance imaging (MRI) of gliomas, the recurrence pattern was classified as close or distant pattern. The relationship between recurrence pattern and CXCL12/CXCR4 expression were initially examined by Chi-squared analysis. The prognostic significance of CXCL12 and CXCR4 was determined by log-rank tests and COX proportional hazards model.</p></div><div><h3>Results</h3><p>CXCL12 was expressed mainly in vascular endothelial cells and CXCR4 was expressed mainly in tumor cells. The recurrence pattern was significantly related to the expression level of CXCL12 in vascular endothelial cells (<em>P</em> <!-->=<!--> <!-->0.002) and CXCR4 in tumor cells (<em>P</em> <!-->=<!--> <!-->0.004). However, CXCL12 and CXCR4 were not independent prognostic factors for progression-free survival or overall survival in glioma patients.</p></div><div><h3>Conclusion</h3><p>The glioma recurrence pattern is related to CXCL12 expression levels in vascular endothelial cells and CXCR4 expression levels in tumor cells; thus, implicating the CXCL12/CXCR4 signaling pathway as a potential target for glioma therapy.</p></div>","PeriodicalId":19743,"journal":{"name":"Pathologie-biologie","volume":"63 4","pages":"Pages 190-198"},"PeriodicalIF":0.0,"publicationDate":"2015-09-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.patbio.2015.07.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"34095115","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 20
Meningococcal vaccines: Current state and future outlook 脑膜炎球菌疫苗:现状和未来展望
Pub Date : 2015-06-01 DOI: 10.1016/j.patbio.2015.04.003
M. Leca , C. Bornet , M. Montana , C. Curti , P. Vanelle

Neisseria meningitidis infections are a major public health problem worldwide. Although conventional approaches have not led to development of a serogroup B meningococcal vaccine, a new technique based on genome sequencing has created new perspectives. Recently, a universal serogroup B meningococcal vaccine, Bexsero®, was licensed in Europe, Australia and United States, following several clinical studies demonstrating its immunogenicity and safety. Availability of this vaccine could contribute positively to human health, by significantly reducing the incidence of meningococcal infections. However, unfavorable cost-effectiveness analysis means that routine vaccination is not currently recommended. Another serogroup meningococcal vaccine, Trumemba®, was also recently licensed in United States. Like any drug, Bexsero® and Trumemba® will require close observation to assess their impact on meningococcal epidemiology.

脑膜炎奈瑟菌感染是世界范围内的一个主要公共卫生问题。尽管传统的方法没有导致血清B群脑膜炎球菌疫苗的开发,但一种基于基因组测序的新技术创造了新的前景。最近,在几项临床研究证明其免疫原性和安全性之后,一种通用血清B群脑膜炎球菌疫苗Bexsero®在欧洲、澳大利亚和美国获得许可。这种疫苗的供应可通过显著降低脑膜炎球菌感染的发生率,对人类健康作出积极贡献。然而,不利的成本效益分析意味着目前不推荐常规疫苗接种。另一种血清群脑膜炎球菌疫苗Trumemba®最近也在美国获得许可。与任何药物一样,Bexsero®和Trumemba®需要密切观察以评估其对脑膜炎球菌流行病学的影响。
{"title":"Meningococcal vaccines: Current state and future outlook","authors":"M. Leca ,&nbsp;C. Bornet ,&nbsp;M. Montana ,&nbsp;C. Curti ,&nbsp;P. Vanelle","doi":"10.1016/j.patbio.2015.04.003","DOIUrl":"10.1016/j.patbio.2015.04.003","url":null,"abstract":"<div><p><em>Neisseria meningitidis</em> infections are a major public health problem worldwide. Although conventional approaches have not led to development of a serogroup B meningococcal vaccine, a new technique based on genome sequencing has created new perspectives. Recently, a universal serogroup B meningococcal vaccine, Bexsero<sup>®</sup>, was licensed in Europe, Australia and United States, following several clinical studies demonstrating its immunogenicity and safety. Availability of this vaccine could contribute positively to human health, by significantly reducing the incidence of meningococcal infections. However, unfavorable cost-effectiveness analysis means that routine vaccination is not currently recommended. Another serogroup meningococcal vaccine, Trumemba<sup>®</sup>, was also recently licensed in United States. Like any drug, Bexsero<sup>®</sup> and Trumemba<sup>®</sup> will require close observation to assess their impact on meningococcal epidemiology.</p></div>","PeriodicalId":19743,"journal":{"name":"Pathologie-biologie","volume":"63 3","pages":"Pages 144-151"},"PeriodicalIF":0.0,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.patbio.2015.04.003","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33314392","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 21
Pathophysiology and treatment of typical and atypical hemolytic uremic syndrome 典型与非典型溶血性尿毒症综合征的病理生理及治疗
Pub Date : 2015-06-01 DOI: 10.1016/j.patbio.2015.03.001
C. Picard , S. Burtey , C. Bornet , C. Curti , M. Montana , P. Vanelle

Hemolytic uremic syndrome is a rare disease, frequently responsible for renal insufficiency in children. Recent findings have led to renewed interest in this pathology. The discovery of new gene mutations in the atypical form of HUS and the experimental data suggesting the involvement of the complement pathway in the typical form, open new perspectives for treatment. This review summarizes the current state of knowledge on both typical and atypical hemolytic uremic syndrome pathophysiology and examines new perspectives for treatment.

溶血性尿毒症是一种罕见的疾病,经常导致儿童肾功能不全。最近的发现重新引起了人们对这种病理的兴趣。非典型溶血性尿毒综合征中新基因突变的发现以及表明典型溶血性尿毒综合征中补体途径参与的实验数据,为治疗开辟了新的前景。本文综述了典型和非典型溶血性尿毒症的病理生理学现状,并探讨了治疗的新观点。
{"title":"Pathophysiology and treatment of typical and atypical hemolytic uremic syndrome","authors":"C. Picard ,&nbsp;S. Burtey ,&nbsp;C. Bornet ,&nbsp;C. Curti ,&nbsp;M. Montana ,&nbsp;P. Vanelle","doi":"10.1016/j.patbio.2015.03.001","DOIUrl":"10.1016/j.patbio.2015.03.001","url":null,"abstract":"<div><p>Hemolytic uremic syndrome is a rare disease, frequently responsible for renal insufficiency in children. Recent findings have led to renewed interest in this pathology. The discovery of new gene mutations in the atypical form of HUS and the experimental data suggesting the involvement of the complement pathway in the typical form, open new perspectives for treatment. This review summarizes the current state of knowledge on both typical and atypical hemolytic uremic syndrome pathophysiology and examines new perspectives for treatment.</p></div>","PeriodicalId":19743,"journal":{"name":"Pathologie-biologie","volume":"63 3","pages":"Pages 136-143"},"PeriodicalIF":0.0,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.patbio.2015.03.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33193586","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 47
Losartan reverses the down-expression of long noncoding RNA-NR024118 and Cdkn1c induced by angiotensin II in adult rat cardiac fibroblasts 氯沙坦逆转血管紧张素II诱导的成年大鼠心脏成纤维细胞中长链非编码RNA-NR024118和Cdkn1c的下调表达
Pub Date : 2015-06-01 DOI: 10.1016/j.patbio.2015.04.001
X. Jiang, F. Zhang, Q. Ning

Angiotensin II (Ang II) plays a pivotal role in the pathogenesis of cardiac fibrosis and long noncoding RNAs (lncRNAs) have been found to be involved in human diseases. The roles of Ang II receptors (AT1 and AT2) have been controversial. Our previous studies revealed that Ang II dynamically down-regulated the expression of lncRNA-NR024118 and Cdkn1c in adult rat cardiac fibroblasts. However, up to now, whether the decrease of lncRNA-NR024118 and Cdkn1c induced by Ang II is mediated by AT1 or AT2 has never been illustrated. In order to reveal which subtype of Ang II receptors mediate the decrease of lncRNA-NR024118 and Cdkn1c induced by Ang II, we studied the expression of NR024118 and Cdkn1c with different receptor blockers in Ang II–treated adult rat cardiac fibroblasts. In this study, we found that losartan (AT1 blocker) nearly completely reversed the decrease of lncRNA-NR024118 and partly reversed the decrease of Cdkn1c induced by Ang II in adult rat cardiac fibroblasts, while AT2 blocker (PD123319) did not show effect to the level of lncRNA-NR024118 and Cdkn1c. In conclusion, our current studies showed that the decrease of lncRNA-NR024118 and Cdkn1c induced by Ang II is mediated by AT1 receptor-dependent not AT2 receptor-dependent, which is helpful to understand the molecular mechanism of Ang II receptors in adult rat cardiac fibroblasts.

血管紧张素II (angii)在心脏纤维化的发病机制中起着关键作用,长链非编码rna (lncRNAs)已被发现参与人类疾病。Ang II受体(AT1和AT2)的作用一直存在争议。我们前期研究发现,Ang II可动态下调成年大鼠心脏成纤维细胞中lncRNA-NR024118和Cdkn1c的表达。然而,到目前为止,Ang II诱导的lncRNA-NR024118和Cdkn1c的降低是由AT1还是AT2介导的,还没有研究结果。为了揭示Ang II受体的哪个亚型介导了Ang II诱导的lncRNA-NR024118和Cdkn1c的降低,我们研究了不同受体阻断剂在Ang II处理的成年大鼠心脏成纤维细胞中NR024118和Cdkn1c的表达。在本研究中,我们发现氯沙坦(AT1阻滞剂)几乎完全逆转了成年大鼠心脏成纤维细胞中lncRNA-NR024118的下降,部分逆转了Ang II诱导的Cdkn1c的下降,而AT2阻滞剂(PD123319)对lncRNA-NR024118和Cdkn1c的水平没有影响。综上所述,我们目前的研究表明,Ang II诱导的lncRNA-NR024118和Cdkn1c的减少是由AT1受体依赖性介导的,而不是AT2受体依赖性,这有助于了解成年大鼠心脏成纤维细胞中Ang II受体的分子机制。
{"title":"Losartan reverses the down-expression of long noncoding RNA-NR024118 and Cdkn1c induced by angiotensin II in adult rat cardiac fibroblasts","authors":"X. Jiang,&nbsp;F. Zhang,&nbsp;Q. Ning","doi":"10.1016/j.patbio.2015.04.001","DOIUrl":"10.1016/j.patbio.2015.04.001","url":null,"abstract":"<div><p>Angiotensin II (Ang II) plays a pivotal role in the pathogenesis of cardiac fibrosis and long noncoding RNAs (lncRNAs) have been found to be involved in human diseases. The roles of Ang II receptors (AT1 and AT2) have been controversial. Our previous studies revealed that Ang II dynamically down-regulated the expression of lncRNA-NR024118 and Cdkn1c in adult rat cardiac fibroblasts. However, up to now, whether the decrease of lncRNA-NR024118 and Cdkn1c induced by Ang II is mediated by AT1 or AT2 has never been illustrated. In order to reveal which subtype of Ang II receptors mediate the decrease of lncRNA-NR024118 and Cdkn1c induced by Ang II, we studied the expression of NR024118 and Cdkn1c with different receptor blockers in Ang II–treated adult rat cardiac fibroblasts. In this study, we found that losartan (AT1 blocker) nearly completely reversed the decrease of lncRNA-NR024118 and partly reversed the decrease of Cdkn1c induced by Ang II in adult rat cardiac fibroblasts, while AT2 blocker (PD123319) did not show effect to the level of lncRNA-NR024118 and Cdkn1c. In conclusion, our current studies showed that the decrease of lncRNA-NR024118 and Cdkn1c induced by Ang II is mediated by AT1 receptor-dependent not AT2 receptor-dependent, which is helpful to understand the molecular mechanism of Ang II receptors in adult rat cardiac fibroblasts.</p></div>","PeriodicalId":19743,"journal":{"name":"Pathologie-biologie","volume":"63 3","pages":"Pages 122-125"},"PeriodicalIF":0.0,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.patbio.2015.04.001","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33308432","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 24
Prenatal diagnosis of cystic fibrosis: 10-years experience 囊性纤维化产前诊断:10年经验
Pub Date : 2015-06-01 DOI: 10.1016/j.patbio.2015.04.002
S. Hadj Fredj , F. Ouali , H. Siala , A. Bibi , R. Othmani , B. Dakhlaoui , F. Zouari , T. Messaoud

Purpose

We present in this study our 10 years experience in prenatal diagnosis of cystic fibrosis performed in the Tunisian population.

Patients and methods

Based on family history, 40 Tunisian couples were selected for prenatal diagnosis. Fetal DNA was isolated from amniotic fluid collected by transabdominal amniocentesis or from chronic villi by transcervical chorionic villus sampling. The genetic analysis for cystic fibrosis mutations was performed by denaturant gradient gel electrophoresis and denaturing high-pressure liquid phase chromatography. We performed microsatellites analysis by capillary electrophoresis in order to verify the absence of maternal cell contamination.

Results

Thirteen fetuses were affected, 21 were heterozygous carriers and 15 were healthy with two normal alleles of CFTR gene. Ten couples opted for therapeutic abortion. The microsatellites genotyping showed the absence of contamination of the fetal DNA by maternal DNA in 93.75%.

Conclusion

Our diagnostic strategy provides rapid and reliable prenatal diagnosis at risk families of cystic fibrosis.

目的:我们在本研究中介绍了我们在突尼斯人群中进行囊性纤维化产前诊断的10年经验。患者和方法根据家族史,选择40对突尼斯夫妇进行产前诊断。通过经腹羊膜穿刺术或经宫颈绒毛膜绒毛取样从羊水中分离胎儿DNA。囊性纤维化突变的遗传分析采用变性梯度凝胶电泳和变性高压液相色谱法。我们通过毛细管电泳进行了微卫星分析,以验证母体细胞污染的存在。结果13例患儿中21例为杂合子携带者,15例健康,CFTR基因等位基因2个正常。10对夫妇选择了治疗性流产。微卫星基因分型显示93.75%的胎儿DNA未被母体DNA污染。结论我们的诊断策略为囊性纤维化高危家庭提供了快速、可靠的产前诊断。
{"title":"Prenatal diagnosis of cystic fibrosis: 10-years experience","authors":"S. Hadj Fredj ,&nbsp;F. Ouali ,&nbsp;H. Siala ,&nbsp;A. Bibi ,&nbsp;R. Othmani ,&nbsp;B. Dakhlaoui ,&nbsp;F. Zouari ,&nbsp;T. Messaoud","doi":"10.1016/j.patbio.2015.04.002","DOIUrl":"10.1016/j.patbio.2015.04.002","url":null,"abstract":"<div><h3>Purpose</h3><p>We present in this study our 10<!--> <!-->years experience in prenatal diagnosis of cystic fibrosis performed in the Tunisian population.</p></div><div><h3>Patients and methods</h3><p>Based on family history, 40 Tunisian couples were selected for prenatal diagnosis. Fetal DNA was isolated from amniotic fluid collected by transabdominal amniocentesis or from chronic villi by transcervical chorionic villus sampling. The genetic analysis for cystic fibrosis mutations was performed by denaturant gradient gel electrophoresis and denaturing high-pressure liquid phase chromatography. We performed microsatellites analysis by capillary electrophoresis in order to verify the absence of maternal cell contamination.</p></div><div><h3>Results</h3><p>Thirteen fetuses were affected, 21 were heterozygous carriers and 15 were healthy with two normal alleles of <em>CFTR</em> gene. Ten couples opted for therapeutic abortion. The microsatellites genotyping showed the absence of contamination of the fetal DNA by maternal DNA in 93.75%.</p></div><div><h3>Conclusion</h3><p>Our diagnostic strategy provides rapid and reliable prenatal diagnosis at risk families of cystic fibrosis.</p></div>","PeriodicalId":19743,"journal":{"name":"Pathologie-biologie","volume":"63 3","pages":"Pages 126-129"},"PeriodicalIF":0.0,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.patbio.2015.04.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33326750","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 5
Cathelicidin related antimicrobial peptide, laminin, Toll-like receptors and chemokines levels in experimental hypersensitivity pneumonitis in mice 实验性过敏性肺炎小鼠抗菌肽相关抗菌肽、层粘连蛋白、toll样受体和趋化因子水平
Pub Date : 2015-06-01 DOI: 10.1016/j.patbio.2015.03.002
M. Golec , M.K. Lemieszek , C. Skórska , J. Sitkowska , J. Zwoliński , B. Mackiewicz , A. Góra-Florek , J. Milanowski , J. Dutkiewicz

Introduction

Hypersensitivity pneumonitis (HP) is an interstitial lung disease caused by unresolved inflammation and tissue repair pathologies triggered by repeated organic dust exposure. The aim of the study was to investigate changes in levels of the cathelicidin related antimicrobial peptide (CRAMP), laminin (LAM-A1), selected Toll-like receptors (TLR) and chemokines in experimental HP in mice.

Materials and methods

Three and 18-month-old female C57BL/6J mice underwent inhalations of the saline extract of Pantoea agglomerans cells, Gram-negative bacterium common in organic dust and known for its pathogenic impact. The inhalations were repeated daily (28 days). ELISA was used for measuring in lung tissue homogenates concentration of CRAMP, LAM-A1, TLR2, TLR4, TLR8, CXCL9 (chemokine [C-X-C motif] ligand) and CXCL10.

Results

Levels of TLR2, TLR4 and CXCL9 were significantly higher in both young and old mice lungs already after 7 days of inhalations, while significant increase of LAM-A1 and CXCL10 was noted after 28 days, compared to untreated samples. TLR8 level was significantly augmented only in young mice. Only CRAMP level significantly declined. Significantly higher TLR8 and CXCL9 concentration in untreated samples were noted in old animals compared to young ones.

Conclusion

Significant alterations of the examined factors levels indicate their role in HP pathogenesis.

超敏性肺炎(hypersensitivity pneumonitis, HP)是一种间质性肺部疾病,由反复接触有机粉尘引发的未解决的炎症和组织修复病理引起。本研究旨在探讨实验性HP小鼠抗菌肽相关抗菌肽(CRAMP)、层粘胶蛋白(LAM-A1)、toll样受体(TLR)和趋化因子水平的变化。材料与方法3个月和18个月大的雌性C57BL/6J小鼠吸入Pantoea agglomerans细胞的生理盐水提取物,Pantoea agglomerans细胞是有机粉尘中常见的革兰氏阴性细菌,具有致病性。每天重复吸入(28 d)。ELISA法检测肺组织匀浆中camp、LAM-A1、TLR2、TLR4、TLR8、CXCL9(趋化因子[C-X-C motif]配体)和CXCL10的浓度。结果与未处理的小鼠相比,吸入7d后,年轻小鼠和老年小鼠肺中TLR2、TLR4和CXCL9的水平均显著升高,而吸入28d后,LAM-A1和CXCL10的水平均显著升高。TLR8水平仅在幼鼠中显著升高。只有抽筋水平明显下降。老龄动物的TLR8和CXCL9浓度明显高于幼龄动物。结论检测因子水平的显著变化提示其在HP发病中的作用。
{"title":"Cathelicidin related antimicrobial peptide, laminin, Toll-like receptors and chemokines levels in experimental hypersensitivity pneumonitis in mice","authors":"M. Golec ,&nbsp;M.K. Lemieszek ,&nbsp;C. Skórska ,&nbsp;J. Sitkowska ,&nbsp;J. Zwoliński ,&nbsp;B. Mackiewicz ,&nbsp;A. Góra-Florek ,&nbsp;J. Milanowski ,&nbsp;J. Dutkiewicz","doi":"10.1016/j.patbio.2015.03.002","DOIUrl":"10.1016/j.patbio.2015.03.002","url":null,"abstract":"<div><h3>Introduction</h3><p>Hypersensitivity pneumonitis (HP) is an interstitial lung disease caused by unresolved inflammation and tissue repair pathologies triggered by repeated organic dust exposure. The aim of the study was to investigate changes in levels of the cathelicidin related antimicrobial peptide (CRAMP), laminin (LAM-A1), selected Toll-like receptors (TLR) and chemokines in experimental HP in mice.</p></div><div><h3>Materials and methods</h3><p>Three and 18-month-old female C57BL/6J mice underwent inhalations of the saline extract of <em>Pantoea agglomerans</em> cells, Gram-negative bacterium common in organic dust and known for its pathogenic impact. The inhalations were repeated daily (28 days). ELISA was used for measuring in lung tissue homogenates concentration of CRAMP, LAM-A1, TLR2, TLR4, TLR8, CXCL9 (chemokine [C-X-C motif] ligand) and CXCL10.</p></div><div><h3>Results</h3><p>Levels of TLR2, TLR4 and CXCL9 were significantly higher in both young and old mice lungs already after 7 days of inhalations, while significant increase of LAM-A1 and CXCL10 was noted after 28 days, compared to untreated samples. TLR8 level was significantly augmented only in young mice. Only CRAMP level significantly declined. Significantly higher TLR8 and CXCL9 concentration in untreated samples were noted in old animals compared to young ones.</p></div><div><h3>Conclusion</h3><p>Significant alterations of the examined factors levels indicate their role in HP pathogenesis.</p></div>","PeriodicalId":19743,"journal":{"name":"Pathologie-biologie","volume":"63 3","pages":"Pages 130-135"},"PeriodicalIF":0.0,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.patbio.2015.03.002","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33058362","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 9
Molecular characterization of piebaldism in a Tunisian family 突尼斯一个家庭中piebaldism的分子特征
Pub Date : 2015-06-01 DOI: 10.1016/j.patbio.2015.03.004
E. Kerkeni , S. Boubaker , S. Sfar , M. Bizid , H. Besbes , S. Bouaziz , N. Ghedira , A. Amara , W. Manoubi , M. Gribaa , K. Monastiri

Objective

The present study is aimed at performing the molecular characterization of a Tunisian family with piebaldism.

Methods

As the proband and her mother showed a severe phenotype, we first chose to screen exons 10, 11, 12, 13, 16, 17 and 18 of the KIT proto-oncogene by direct sequencing.

Results

Direct sequencing analysis showed a C to T substitution at 1939 in exon 13 (c.1939C>T) in heterozygous state in the patient and his mother. The mutation was not found in their unaffected family members or normal controls.

Conclusion

Our results provide additional support that mutations in the tyrosine kinase domain of the KIT gene are responsible for the severe form of piebaldism.

目的本研究旨在对突尼斯一个花斑病家族进行分子表征。方法先证者及其母亲表现出严重的表型,我们首先选择直接测序法筛选KIT原癌基因的第10、11、12、13、16、17和18外显子。结果直接测序结果显示,患者及其母亲在杂合状态下,外显子13 (C . 1939c>T) 1939位点出现C - T替换。在他们未受影响的家庭成员或正常对照中没有发现这种突变。结论KIT基因酪氨酸激酶结构域的突变是导致严重的piebaldism的原因。
{"title":"Molecular characterization of piebaldism in a Tunisian family","authors":"E. Kerkeni ,&nbsp;S. Boubaker ,&nbsp;S. Sfar ,&nbsp;M. Bizid ,&nbsp;H. Besbes ,&nbsp;S. Bouaziz ,&nbsp;N. Ghedira ,&nbsp;A. Amara ,&nbsp;W. Manoubi ,&nbsp;M. Gribaa ,&nbsp;K. Monastiri","doi":"10.1016/j.patbio.2015.03.004","DOIUrl":"10.1016/j.patbio.2015.03.004","url":null,"abstract":"<div><h3>Objective</h3><p>The present study is aimed at performing the molecular characterization of a Tunisian family with piebaldism.</p></div><div><h3>Methods</h3><p>As the proband and her mother showed a severe phenotype, we first chose to screen exons 10, 11, 12, 13, 16, 17 and 18 of the <em>KIT</em> proto-oncogene by direct sequencing.</p></div><div><h3>Results</h3><p>Direct sequencing analysis showed a C to T substitution at 1939 in exon 13 (c.1939C&gt;T) in heterozygous state in the patient and his mother. The mutation was not found in their unaffected family members or normal controls.</p></div><div><h3>Conclusion</h3><p>Our results provide additional support that mutations in the tyrosine kinase domain of the <em>KIT</em> gene are responsible for the severe form of piebaldism.</p></div>","PeriodicalId":19743,"journal":{"name":"Pathologie-biologie","volume":"63 3","pages":"Pages 113-116"},"PeriodicalIF":0.0,"publicationDate":"2015-06-01","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1016/j.patbio.2015.03.004","citationCount":null,"resultStr":null,"platform":"Semanticscholar","paperid":"33249079","PeriodicalName":null,"FirstCategoryId":null,"ListUrlMain":null,"RegionNum":0,"RegionCategory":"","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":"","EPubDate":null,"PubModel":null,"JCR":null,"JCRName":null,"Score":null,"Total":0}
引用次数: 4
期刊
Pathologie-biologie
全部 Acc. Chem. Res. ACS Applied Bio Materials ACS Appl. Electron. Mater. ACS Appl. Energy Mater. ACS Appl. Mater. Interfaces ACS Appl. Nano Mater. ACS Appl. Polym. Mater. ACS BIOMATER-SCI ENG ACS Catal. ACS Cent. Sci. ACS Chem. Biol. ACS Chemical Health & Safety ACS Chem. Neurosci. ACS Comb. Sci. ACS Earth Space Chem. ACS Energy Lett. ACS Infect. Dis. ACS Macro Lett. ACS Mater. Lett. ACS Med. Chem. Lett. ACS Nano ACS Omega ACS Photonics ACS Sens. ACS Sustainable Chem. Eng. ACS Synth. Biol. Anal. Chem. BIOCHEMISTRY-US Bioconjugate Chem. BIOMACROMOLECULES Chem. Res. Toxicol. Chem. Rev. Chem. Mater. CRYST GROWTH DES ENERG FUEL Environ. Sci. Technol. Environ. Sci. Technol. Lett. Eur. J. Inorg. Chem. IND ENG CHEM RES Inorg. Chem. J. Agric. Food. Chem. J. Chem. Eng. Data J. Chem. Educ. J. Chem. Inf. Model. J. Chem. Theory Comput. J. Med. Chem. J. Nat. Prod. J PROTEOME RES J. Am. Chem. Soc. LANGMUIR MACROMOLECULES Mol. Pharmaceutics Nano Lett. Org. Lett. ORG PROCESS RES DEV ORGANOMETALLICS J. Org. Chem. J. Phys. Chem. J. Phys. Chem. A J. Phys. Chem. B J. Phys. Chem. C J. Phys. Chem. Lett. Analyst Anal. Methods Biomater. Sci. Catal. Sci. Technol. Chem. Commun. Chem. Soc. Rev. CHEM EDUC RES PRACT CRYSTENGCOMM Dalton Trans. Energy Environ. Sci. ENVIRON SCI-NANO ENVIRON SCI-PROC IMP ENVIRON SCI-WAT RES Faraday Discuss. Food Funct. Green Chem. Inorg. Chem. Front. Integr. Biol. J. Anal. At. Spectrom. J. Mater. Chem. A J. Mater. Chem. B J. Mater. Chem. C Lab Chip Mater. Chem. Front. Mater. Horiz. MEDCHEMCOMM Metallomics Mol. Biosyst. Mol. Syst. Des. Eng. Nanoscale Nanoscale Horiz. Nat. Prod. Rep. New J. Chem. Org. Biomol. Chem. Org. Chem. Front. PHOTOCH PHOTOBIO SCI PCCP Polym. Chem.
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1